Table 2 Patients’ clinical characteristics for validation set (n = 86)

Sex, F/M

61.90%

62.50%

P = 0.983^a

Age, years

59.56 ± 17.131

63.48 ± 17.927

P = 0.316^b

 Pulmonary

58.00% (29)

42.00% (21)

P < 0.001^a

 Biliary system and pancreatic

45.50% (5)

54.50% (6)

P = 0.276^a

 Peritonitis

78.90% (15)

21.10% (4)

P < 0.001^a

 Urinary system

60.00% (3)

40.00% (2)

P = 0.380^a

 Cerebral

0% (0)

100% (1)

P = 1.000^a

SOFA scores

6.68 ± 3.67

6.04 ± 3.16

P = 0.393^b

APACHE II scores

17.35 ± 7.88

16.60 ± 6.73

P = 0.635^b

28-day mortality%

67.7% (21)

32.3% (10)

P < 0.001^a

PLT (×10^9/L)

108.03 ± 91.99

211.10 ± 96.93

P < 0.001^b

D-dimer (mg/dL)

7.12 (3.00, 18.24)

4.60 (2.38, 8.64)

P < 0.001^c

APTT (s)

44.80 (38.10, 61.10)

35.75 (31.70, 43.23)

P < .001^c

PT (s)

14.90 (13.48, 17.33)

12.75 (11.53, 13.88)

P < 0.001^c

PA%

66.53 ± 17.89

81.10 ± 11.98

P < 0.001^c

INR

1.26 (1.16, 1.47)

1.11 (1.03, 1.18)

P < 0.001^c

Fbg (mg/dL)

275.13 ± 136.45

421.50 ± 173.30

P < 0.001^b

TT (s)

20.00 (18.28, 24.88)

19.10 (17.98, 20.70)

P = 0.055^c

Cr (mmol/L)

75.65 (52.90, 137.20)

74.25 (53.80, 127.65)

P = 0.575^c

BUN (mmol/L)

10.12 (5.78, 14.07)

8.54 (5.06, 12.78)

P = 0.299^c